top of page

Why PsyBio Will be the Leader in the Psychedelic Drug Discovery Industry:

1_2x.png

IP Protected Bio synthetic pathway for candidate production

2_2x.png

Ability to Manufacture and conduct invitro & invivo efficacy testing and conduct human 

clinical trial psychedelic inspired compound discovery and production

3_2x.png

Portfolio of psycho-targeted biotherapeutics manufacturing organizations for process development and commercialization of lead
compounds

4.png

Robust and expanding intellectual property portfolio encompassing twenty-nine patent submission covering thousands of molecules including compositions of matter, interactions, manufacturing and methods of use.

5.png

In preparation for potential clinical partnership(s) for funded human subject clinical trial(s) analyzing

bio-synthetic psilocybin for the treatment of two different mental health conditions.

6.png

Second drug candidate in IND preparation exhibiting similar therapeutic properties as psilocybin without the hallucinogenic effect.

band _edited.png

PsyBio is one of a small number of companies actively working towards US FDA sanctioned clinical trials in the psychedelic inspired biotherapeutic space.

Milestones

Asset 2.png

US and EU clinical trial initiation Q4 2023.

Asset 2.png

FDA and EMA submissions

 for US and/or EU clinical trials Q4 2023.

Completed Pre-IND Type C meeting affirming pre-clinical requirements and clinical indications.

Asset 2.png

Completion of cGMP manufacturing development Q4 2023.

Asset 2.png

IND preparation for second generation non- hallucinatory drug candidate

psybio background.png
button.png

PsyBio Advantage: Bio-Medicinal Chemistry

Group 2080.png

Agricultural Production and Extraction

Agricultural_Prod_4.png
Agricultural_Prod_3.png
Agricultural_Prod_2.png
Group 2080.png

Chemical Synthetic Production

Chemical_Prod_2.png
Chemical_Prod_3.png
Chemical_Prod_4.png
background.png
Group 2080_edited.png

PsyBio Advantage :
Bio-Synthetic Production

Psybio Advantage2.png
Psybio Advantage1.png
Psybio Advantage3.png

Highly Flexible Biosynthetic Production

STARTING MATERIAL 1

STARTING MATERIAL 2

STARTING MATERIAL 3

STARTING MATERIAL 4

STARTING MATERIAL 5

STARTING MATERIAL 6

Compound 1
Bioreactor.png

purification

purification

purification

purification

purification

purification

Compound 2
Group 2034.png

FINAL PRODUCT 6

Group 2041.png

FINAL PRODUCT 5

Group 2048.png

FINAL PRODUCT 4

Group 2055.png

FINAL PRODUCT 3

Group 2062.png

FINAL PRODUCT 2

Group 2064.png

FINAL PRODUCT 1

BIO Synthetic Production

bottom of page